Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs01779660

Ligand	Ligand name	Chain	PDB	Tanimoto
EZT	(17BETA)-17-{(E)-2-[2-(TRIFLUOROMETHYL)PHENYL]VINYL}ESTRA-1(10),2,4-TRIENE-3,17-DIOL	A,B	2P15	0.75
BPZ	4,4'-cyclohexane-1,1-diyldiphenol	A	2ZKC	0.72
DRQ	(9ALPHA,13BETA,17BETA)-2-[(1Z)-BUT-1-EN-1-YL]ESTRA-1,3,5(10)-TRIENE-3,17-DIOL	A,B	2G5O	0.74
196	3-(3-FLUORO-4-HYDROXYPHENYL)-7-HYDROXY-1-NAPHTHONITRILE	A,B	1YYE	0.72
EQU	EQUILENIN	A,B	1OGX	0.73
EQU	EQUILENIN	A,B,C,D,E,F	1QJG	0.73
EQU	EQUILENIN	A,B	1OH0	0.73
EQU	EQUILENIN	A	1W6Y	0.73
EQU	EQUILENIN	A,B	1CQS	0.73
EQU	EQUILENIN	A	1OGZ	0.73
EQU	EQUILENIN	A	1GS3	0.73
EQU	EQUILENIN	A	1OHO	0.73
ETC	(R,R)-5,11-CIS-DIETHYL-5,6,11,12-TETRAHYDROCHRYSENE-2,8-DIOL	A,B	1L2I	0.73
ETC	(R,R)-5,11-CIS-DIETHYL-5,6,11,12-TETRAHYDROCHRYSENE-2,8-DIOL	A,B	1L2J	0.73
CZM	'N,N'-BIS-(2-HYDROXY-3-METHYL-BENZYLIDENE)-BENZENE-1,2-DIAMINE'	A	1J3F	0.7
CZM	'N,N'-BIS-(2-HYDROXY-3-METHYL-BENZYLIDENE)-BENZENE-1,2-DIAMINE'	A	1UFJ	0.7
CZM	'N,N'-BIS-(2-HYDROXY-3-METHYL-BENZYLIDENE)-BENZENE-1,2-DIAMINE'	A	1V9Q	0.7
ANF	ANTHRONE	H	2BJM	0.73
2E3	(2E)-3-[4-hydroxy-3-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydronaphthalen-2-yl)phenyl]prop-2-enoic acid	A	3FUG	0.71
MA0	(1R)-6-HYDROXY-N-METHYL-N-[(1Z)-PROP-2-EN-1-YLIDENE]INDAN-1-AMINIUM	A,B	2C64	0.72
EST	ESTRADIOL	A,B	1GWR	0.73
EST	ESTRADIOL	A	1FDS	0.73
EST	ESTRADIOL	A,B,C	1G50	0.73
EST	ESTRADIOL	A,B,C,D,E,F	1ERE	0.73
EST	ESTRADIOL	A,B	1A52	0.73
EST	ESTRADIOL	A	1FDT	0.73
EST	ESTRADIOL	A	2OCF	0.73
EST	ESTRADIOL	A,B,C	1QKU	0.73
EST	ESTRADIOL	A,B,C,D,L	1E6W	0.73
EST	ESTRADIOL	A	1IOL	0.73
EST	ESTRADIOL	H	1JNN	0.73
EST	ESTRADIOL	B	1QKT	0.73
EST	ESTRADIOL	A	1FDW	0.73
EST	ESTRADIOL	A,B	1AQU	0.73
EST	ESTRADIOL	A	1LHU	0.73
EST	ESTRADIOL	A	1A27	0.73
EST	ESTRADIOL	L	1JGL	0.73
EST	ESTRADIOL	A,B,E,F	1PCG	0.73
EST	ESTRADIOL	A,B,C,D	1FDU	0.73
EST	ESTRADIOL	A	2J7X	0.73
EST	ESTRADIOL	A,B	2D06	0.73
DIN	1,6-DIHYDROXY NAPHTHALENE	A	1ZB6	0.71
555	4-(4-HYDROXYPHENYL)-1-NAPHTHALDEHYDE OXIME	A,B	2NV7	0.8
17M	17-METHYL-17-ALPHA-DIHYDROEQUILENIN	A,B	2B1Z	0.77
C3D	(5R,6S)-6-PHENYL-5-[4-(2-PYRROLIDIN-1-YLETHOXY)PHENYL]-5,6,7,8-TETRAHYDRONAPHTHALEN-2-OL	A	2OUZ	0.7
RM2	4-HYDROXY-N-PROPARGYL-1(R)-AMINOINDAN	A,B	2C66	0.72
AOE	N-BUTYL-11-[(7R,8R,9S,13S,14S,17S)-3,17-DIHYDROXY-13-METHYL-7,8,9,11,12,13,14,15,16,17-DECAHYDRO-6H-CYCLOPENTA[A]PHENANTHREN-7-YL]-N-METHYLUNDECANAMIDE	A	1HJ1	0.7
1OH	4-(1-methyl-1-phenylethyl)phenol	A	2ZAS	0.7
BM4	3-[(3R)-3-ethyl-1-{9-[(3S)-3-ethyl-3-(3-hydroxyphenyl)azepan-1-yl]nonyl}azepan-3-yl]phenol	X	2W6C	0.7
55E	4-(4-hydroxy-3-methylphenyl)-6-phenylpyrimidin-2(5H)-one	A	3DCV	0.7
1NP	1-NAPHTHOL	X	2ZVQ	0.72
EED	(9BETA,11ALPHA,13ALPHA,14BETA,17ALPHA)-11-(METHOXYMETHYL)ESTRA-1(10),2,4-TRIENE-3,17-DIOL	A,B	2QGT	0.71
E3O	(16ALPHA,17ALPHA)-ESTRA-1,3,5(10)-TRIENE-3,16,17-TRIOL	A	2J7Y	0.72
AED	4-(2-aminoethyl)-2-cyclohexylphenol	A	3BUH	0.73
ESL	ESTRIOL	A	1X8V	0.72